UCSF researchers reveal how some gene mutations lead to autism spectrum disorder. A new collaborative approach has begun revealing, in detail, how a set of around 100 autism spectrum disorder genes may lead to serious developmental problems. The technique involves looking beyond genes and their mutations, to the proteins they code for.
Thirty-two UCSF scientists are among the most influential individuals in their respective fields, according to the most recent analysis of research citations by the science and intellectual property company, Clarivate.
Brainstem recording shows that our tastebuds are the first line of defense against eating too fast. Understanding how may lead to new avenues for weight loss. A previously unknown signaling cycle stemming from our sense of taste helps suppress our appetites.
Grapes’ exposure to sun appears to increase compound that blocks metabolism of alcohol. Researchers offer a theory for why many people experience headaches as soon as 30 minutes after drinking red wine.
New test could change treatment for 1 in 3 patients with meningioma. A gene expression test can accurately predict the best treatment for meningioma patients by measuring the aggressiveness of their tumors and adjusting treatment accordingly.
Scientists discover a role for the nervous system in keeping itch and allergy under control. Scientists found that the nervous system tamps down allergic response, which could change how asthma, Crohn’s and other inflammatory diseases are treated.
UCSF-led trial will combine an anti-amyloid with tau therapies to arrest disease progression. A new study will combine an Alzheimer’s medication that slows disease progression in some patients with two other drugs to see if their effects can be amplified.
UCSF-led study puts MDMA on path to be the first psychedelic to seek FDA approval. A clinical trial showed that MDMA, the so-called psychedelic drug also known as "ecstasy" or "molly," can be a powerful new tool in treating people with moderate-to-severe PTSD.
Breakthrough brain implant and digital avatar allow stroke survivor to speak with facial expressions for first time in 18 years. A brain implant and digital avatar allow a paralyzed stroke survivor to speak with for first time in 18 years with the help of artificial intelligence.